Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34962825)

  • 1. Rhomboid domain containing 1 promotes the growth of non-small cell lung cancer through the activation of EGFR and regulation of the BIK-mediated apoptosis.
    Xu ZY; Li X; Yao RH; Yang LM; Peng H; Ren WJ; Lu H; Wang P
    Neoplasma; 2022 Mar; 69(2):311-320. PubMed ID: 34962825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RHBDD1 silencing inhibited cell growth and invasion of non-small cell lung cancer by mediating ZEB1/PI3K/AKT signaling pathway.
    Xu Z; Wang R; Li X; Yang L; Peng H; Wang Y; Wang P
    J Mol Histol; 2021 Jun; 52(3):503-510. PubMed ID: 33515112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
    Niu Y; Zhang J; Tong Y; Li J; Liu B
    Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
    Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhomboid domain-containing protein 1 promotes breast cancer progression by regulating the p-Akt and CDK2 levels.
    Zhang X; Zhao Y; Wang C; Ju H; Liu W; Zhang X; Miao S; Wang L; Sun Q; Song W
    Cell Commun Signal; 2018 Oct; 16(1):65. PubMed ID: 30286765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 7. Silibinin suppresses epithelial-mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1.
    Xu S; Zhang H; Wang A; Ma Y; Gan Y; Li G
    Cell Mol Biol Lett; 2020; 25():36. PubMed ID: 32528541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel member of the Rhomboid family, RHBDD1, regulates BIK-mediated apoptosis.
    Wang Y; Guan X; Fok KL; Li S; Zhang X; Miao S; Zong S; Koide SS; Chan HC; Wang L
    Cell Mol Life Sci; 2008 Nov; 65(23):3822-9. PubMed ID: 18953687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldolase A promotes proliferation and G
    Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
    Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral vector mediated delivery of RHBDD1 shRNA down regulated the proliferation of human glioblastoma cells.
    Wei X; Lv T; Chen D; Guan J
    Technol Cancer Res Treat; 2014 Feb; 13(1):87-93. PubMed ID: 23883433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-924 as a tumor suppressor inhibits non-small cell lung cancer by inhibiting RHBDD1/Wnt/β-catenin signaling pathway.
    Wang H; Chen X; Yang B; Xia Z; Chen Q
    Cancer Cell Int; 2020; 20():491. PubMed ID: 33041671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FoxO3a inhibiting expression of EPS8 to prevent progression of NSCLC: A new negative loop of EGFR signaling.
    Wen Q; Jiao X; Kuang F; Hou B; Zhu Y; Guo W; Sun G; Ba Y; Yu D; Wang D; Zhang F; Qiao HC; Wang S; Tang S; Qiao H
    EBioMedicine; 2019 Feb; 40():198-209. PubMed ID: 30738830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer.
    Zhang J; Sun B; Ruan X; Hou X; Zhi J; Meng X; Zheng X; Gao M
    Cancer Biol Med; 2021 Feb; 18(1):105-119. PubMed ID: 33628588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel via EGFR-pAKT Pathway.
    Xu F; Gu J; Lu C; Mao W; Wang L; Zhu Q; Liu Z; Chu Y; Liu R; Ge D
    Int J Biol Sci; 2019; 15(1):127-137. PubMed ID: 30662353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway.
    Zhou J; Kwak KJ; Wu Z; Yang D; Li J; Chang M; Song Y; Zeng H; Lee LJ; Hu J; Bai C
    Cell Physiol Biochem; 2018; 47(5):1909-1924. PubMed ID: 29961070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long non-coding RNA PVT1/miR-145-5p/ITGB8 axis regulates cell proliferation, apoptosis, migration and invasion in non-small cell lung cancer cells.
    Wei CM; Zhao XF; Qiu HB; Ming Z; Liu K; Yan J
    Neoplasma; 2020 Jul; 67(4):802-812. PubMed ID: 32202906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
    Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhomboid domain containing 1 promotes colorectal cancer growth through activation of the EGFR signalling pathway.
    Song W; Liu W; Zhao H; Li S; Guan X; Ying J; Zhang Y; Miao F; Zhang M; Ren X; Li X; Wu F; Zhao Y; Tian Y; Wu W; Fu J; Liang J; Wu W; Liu C; Yu J; Zong S; Miao S; Zhang X; Wang L
    Nat Commun; 2015 Aug; 6():8022. PubMed ID: 26300397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetyl-11-keto-β-boswellic acid enhances the cisplatin sensitivity of non-small cell lung cancer cells through cell cycle arrest, apoptosis induction, and autophagy suppression via p21-dependent signaling pathway.
    Lv M; Zhuang X; Zhang Q; Cheng Y; Wu D; Wang X; Qiao T
    Cell Biol Toxicol; 2021 Apr; 37(2):209-228. PubMed ID: 32562082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
    Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
    J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.